SEC Company Response from IMPLANT SCIENCES CORP (CIK 0001068874) — Jun 30, 2005

IMPLANT SCIENCES CORP (CIK 0001068874)
Date: June 30, 2005 · CIK: 0001068874 · Accession: 0001047469-05-018545

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-124058

Date

July 1, 2005

Author

Implant Sciences Corporation

Form

CORRESP

Company

IMPLANT SCIENCES CORP (CIK 0001068874)

Letter

VIA EDGAR AND FACSIMILE United States Securities and Exchange Commission Division of Corporate Finance 450 Fifth Street, N.W. Washington, DC 20549 Re:Implant Sciences Corporation (the "Registrant") File No. 333-124058 (the "Registration Statement")

Dear Sir:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Registrant hereby requests acceleration of effectiveness of its Registration Statement so that it will become effective at 10:00 A.M. on Friday, July 1, 2005 or as soon as thereafter practicable.

The Registrant acknowledges that:

•Should the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

•The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

•The Registrant may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If you have any questions or comments, please feel free to contact me at your earliest convenience.

Very
truly yours,
Implant Sciences Corporation

Show Raw Text

CORRESP
1
filename1.htm

IMPLANT SCIENCES CORPORATION

107 AUDUBON ROAD #5

WAKEFIELD, MA 01880

June 30,
2005

VIA EDGAR AND FACSIMILE

Jay
S. Mumford, Esq.

United States Securities and Exchange Commission

Division of Corporate Finance

450 Fifth Street, N.W.

Washington, DC 20549

Re:Implant Sciences Corporation (the "Registrant")

File No. 333-124058 (the "Registration Statement")

Dear
Sir:

        Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the Registrant hereby requests acceleration of effectiveness of its Registration Statement so that it will
become effective at 10:00 A.M. on Friday, July 1, 2005 or as soon as thereafter practicable.

        The
Registrant acknowledges that:

•Should
the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking
any action with respect to the Registration Statement;

•The
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from
its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

•The
Registrant may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

        If
you have any questions or comments, please feel free to contact me at your earliest convenience.

Very
truly yours,

Implant Sciences Corporation

By: /s/  DIANE RYAN

Diane Ryan, Chief Financial Officer

cc:
David Selengut, Esq.

SecProbe.io